ÌÇÐÄvlog

This Viewpoint describes considerations for regulatory oversight in the implementation of artificial intelligence–enabled prognostic devices.

This study describes the characteristics of amyloid-related imaging abnormalities and risk factors and clinical consequences of amyloid-related imaging abnormalities-edema.

This systematic review examines reports about immunoglobulin G4–related pachymeningitis to review and synthesize information about its clinical presentation, investigation findings, and prognosis to better understand diagnosis and management.

This cross-sectional study assesses changes in gender, racial, and ethnic representation among US neurology faculty from 1972 to 2021.

This Viewpoint challenges conventional clinical practice that eschews pharmacological intervention for comatose patients with epileptiform abnormalities after cardiac arrest using evidence from the Treatment of Electroencephalographic Status Epilepticus after Cardiopulmonary Resuscitation (TELSTAR) trial.

This cohort study investigates when the degree of frailty accelerates before dementia and how it is associated with dementia risk.

This essay describes the microaggressions and burnout faced by physicians and the importance of boundaries to preserve physicians’ humanity and well-being.

This randomized clinical trial investigates whether the brain-permeable iron chelator deferiprone slows cognitive decline in people with Alzheimer disease.

This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and variability in the clinical prognosis of patients diagnosed with AD may be introduced.